Copyright
©The Author(s) 2023.
World J Gastrointest Pharmacol Ther. Dec 12, 2023; 14(5): 39-49
Published online Dec 12, 2023. doi: 10.4292/wjgpt.v14.i5.39
Published online Dec 12, 2023. doi: 10.4292/wjgpt.v14.i5.39
Table 3 Diarrhea predominant irritable bowel syndrome responder analysis
| Characteristic | n (%) |
| BSFS responder (n = 100) | 40 (40%) |
| Pain responder (n = 96) | 51 (53%) |
| Discomfort responder (n = 96) | 53 (55%) |
| Composite responder (pain) (n = 96) | 24 (25%) |
| Composite responder (discomfort) (n = 96) | 24 (25%) |
| IBS-SSS (n = 71) | 36 (51%) |
- Citation: Niles SE, Blazy P, Cheuvront SN, Kenefick RW, Vidyasagar S, Smith AB, Fawkes N, Denman W. Effectiveness of an amino acid beverage formulation in diarrhea-predominant irritable bowel syndrome: A pragmatic real-world study. World J Gastrointest Pharmacol Ther 2023; 14(5): 39-49
- URL: https://www.wjgnet.com/2150-5349/full/v14/i5/39.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v14.i5.39